title: MDMA modulates spontaneous firing of subthalamic nucleus neurons in vitro.
abstract: 3,4-Methylene-dioxy-N-methylamphetamine (MDMA, 'ecstasy') has a broad spectrum of molecular targets in the brain, among them receptors and transporters of the serotonergic (5-hydroxytryptamine, 5-HT) and noradrenergic systems. Its action on the serotonergic system modulates motor systems in rodents and humans. Although parts of the basal ganglia could be identified as mediators of the motor effects of MDMA, very little is known about the role of the subthalamic nucleus (STN). Therefore, this study investigated the modulation of spontaneous action potential activity of the STN by MDMA (2.5-20 µM) in vitro. MDMA had very heterogeneous effects, ranging from a complete but reversible inhibition to a more than twofold increase in firing at 5 µM. On average, MDMA excited STN neurons moderately, but lost its excitatory effect in the presence of the 5-HT(2A) antagonist MDL 11,939. 5-HT(1A) receptors did not appear to play a major role. Effects of MDMA on transporters for serotonin (SERT) and norepinephrine (NET) were investigated by coapplication of the reuptake inhibitors citalopram and desipramine, respectively. Similar to the effects of 5-HT(2A) receptor blockade, antagonism of SERT and NET bestowed an inhibitory effect on MDMA. From these results, we conclude that both the 5-HT and the noradrenergic system mediate MDMA-induced effects on STN neurons.
authors.affiliation: Experimental Anaesthesiology Section, University Hospital Tübingen, Waldhörnlestr. 22, 72072, Tübingen, Germany.
authors.forename: Luise
authors.initials: L
authors.lastname: Liebig
authors.forename: Andreas
authors.initials: A
authors.lastname: von Ameln-Mayerhofer
authors.forename: Harald
authors.initials: H
authors.lastname: Hentschke
mesh_terms: D000200:Action Potentials / Q000187:drug effects* / Q000502:physiology; D018759:Adrenergic Uptake Inhibitors / Q000494:pharmacology; D000818:Animals; D015283:Citalopram / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D008297:Male; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000494:pharmacology*; D009474:Neurons / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D018490:Serotonin Agents / Q000494:pharmacology; D020531:Subthalamic Nucleus / Q000166:cytology / Q000187:drug effects* / Q000502:physiology
chemical_list: D018759:Adrenergic Uptake Inhibitors; D018490:Serotonin Agents; D015283:Citalopram; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D003891:Desipramine